BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 29249315)

  • 21. The immunomodulation-immunogenicity balance of equine Mesenchymal Stem Cells (MSCs) is differentially affected by the immune cell response depending on inflammatory licensing and major histocompatibility complex (MHC) compatibility.
    Cequier A; Vázquez FJ; Romero A; Vitoria A; Bernad E; García-Martínez M; Gascón I; Barrachina L; Rodellar C
    Front Vet Sci; 2022; 9():957153. PubMed ID: 36337202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation affects the viability and plasticity of equine mesenchymal stem cells: possible implications in intra-articular treatments.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
    J Vet Sci; 2017 Mar; 18(1):39-49. PubMed ID: 27297420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Priming TLR3 and TLR4 in human adipose- and olfactory mucosa-derived mesenchymal stromal cells and comparison of their cytokine secretions.
    Jafari M; Asghari A; Delbandi AA; Jalessi M; Jazayeri MH; Samarei R; Tajik N
    Cytotechnology; 2020 Feb; 72(1):57-68. PubMed ID: 31898754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of TLR3 priming conditions on MSC immunosuppressive properties.
    Tolstova T; Dotsenko E; Kozhin P; Novikova S; Zgoda V; Rusanov A; Luzgina N
    Stem Cell Res Ther; 2023 Nov; 14(1):344. PubMed ID: 38031182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source.
    Carrade Holt DD; Wood JA; Granick JL; Walker NJ; Clark KC; Borjesson DL
    Stem Cells Dev; 2014 Jun; 23(11):1258-65. PubMed ID: 24438346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allo-antibody production after intraarticular administration of mesenchymal stem cells (MSCs) in an equine osteoarthritis model: effect of repeated administration, MSC inflammatory stimulation, and equine leukocyte antigen (ELA) compatibility.
    Barrachina L; Cequier A; Romero A; Vitoria A; Zaragoza P; Vázquez FJ; Rodellar C
    Stem Cell Res Ther; 2020 Feb; 11(1):52. PubMed ID: 32028995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion.
    Zimmermann JA; McDevitt TC
    Cytotherapy; 2014 Mar; 16(3):331-45. PubMed ID: 24219905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs.
    Remacha AR; Barrachina L; Álvarez-Arguedas S; Ranera B; Romero A; Vázquez FJ; Zaragoza P; Yañez R; Martín-Burriel I; Rodellar C
    Vet Immunol Immunopathol; 2015 Jun; 165(3-4):107-18. PubMed ID: 25977164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
    Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
    Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of poly I:C or LPS priming on the therapeutic efficacy of mesenchymal stem cells in an adjuvant-induced arthritis rat model.
    Zolfaghari S; Milan PB; Dehpour AR; Fomeshi MR; Eskandari F; Ebrahimi L; Hashemi SM; Joghataei MT
    Pharmacol Rep; 2022 Aug; 74(4):654-668. PubMed ID: 35842893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunomodulatory properties of mesenchymal stem cells derived from dental pulp and dental follicle are susceptible to activation by toll-like receptor agonists.
    Tomic S; Djokic J; Vasilijic S; Vucevic D; Todorovic V; Supic G; Colic M
    Stem Cells Dev; 2011 Apr; 20(4):695-708. PubMed ID: 20731536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype.
    Koippallil Gopalakrishnan Nair AR; Pandit H; Warty N; Madan T
    Int Immunol; 2015 Apr; 27(4):195-204. PubMed ID: 25416515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T Lymphocyte Prestimulation Impairs in a Time-Dependent Manner the Capacity of Adipose Mesenchymal Stem Cells to Inhibit Proliferation: Role of Interferon γ, Poly I:C, and Tryptophan Metabolism in Restoring Adipose Mesenchymal Stem Cell Inhibitory Effect.
    Mancheño-Corvo P; Menta R; del Río B; Franquesa M; Ramírez C; Hoogduijn MJ; DelaRosa O; Dalemans W; Lombardo E
    Stem Cells Dev; 2015 Sep; 24(18):2158-70. PubMed ID: 26058889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tonsil-derived mesenchymal stromal cells produce CXCR2-binding chemokines and acquire follicular dendritic cell-like phenotypes under TLR3 stimulation.
    Ryu JH; Park M; Kim BK; Ryu KH; Woo SY
    Cytokine; 2015 Jun; 73(2):225-35. PubMed ID: 25794662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.
    Park A; Park H; Yoon J; Kang D; Kang MH; Park YY; Suh N; Yu J
    Stem Cell Res Ther; 2019 Feb; 10(1):66. PubMed ID: 30795812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells.
    Martinez VG; Ontoria-Oviedo I; Ricardo CP; Harding SE; Sacedon R; Varas A; Zapata A; Sepulveda P; Vicente A
    Stem Cell Res Ther; 2017 Sep; 8(1):208. PubMed ID: 28962641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis.
    Lim JY; Im KI; Lee ES; Kim N; Nam YS; Jeon YW; Cho SG
    Sci Rep; 2016 Jun; 6():26851. PubMed ID: 27246365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
    Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
    Zimmermann JA; Hettiaratchi MH; McDevitt TC
    Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of local anesthetic on pro-inflammatory macrophage modulation by mesenchymal stromal cells.
    Gray A; Marrero-Berrios I; Weinberg J; Manchikalapati D; SchianodiCola J; Schloss RS; Yarmush J
    Int Immunopharmacol; 2016 Apr; 33():48-54. PubMed ID: 26854576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.